Clinical Trial Update: Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whole-brain radiation therapy or stereotactic radiosurgery with or without lapatinib for brain metastases from HER2-positive breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastasis
• Breast Cancer

Drugs mentioned

• Lapatinib Ditosylate (lapatinib ditosylate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-04-13